Skip to main content
Clinical Trials/CTRI/2024/07/070242
CTRI/2024/07/070242Not yet recruitingPhase 3 4

Quality of Recovery (q0R 15) following administration of intravenous vs epidural opioids and non opioids in oncological abdominal surgeries under GA.

Arpita Thombre1 site in 1 country80 target enrollmentStarted: July 15, 2024Last updated:

Trial Snapshot

Phase
Phase 3 4
Status
Not yet recruiting
Sponsor
Enrollment
80
Locations
1
Primary Endpoint
Postoperative Quality of recovery using QoR 15 score

Study Overview

Brief Summary

This study is a prospective randomized controlled study comparing postoperative quality of recovery using QoR 15 questionnaire  after administration of intravenous versus epidural opioids or non opioids in patients undergoing oncological abdominal surgeries under general anaesthesia. There are fours groups i.e. Group A will receive intravenous fentanyl 1-2 mcg as premedication, Group B will receive intravenous paracetamol 1 gm, Group C will receive Inj Bupivacaine 0.25% 8ml via epidural catheter, Group D will receive Inj Bupivacaine 0.25% with fentanyl 0.3mcg/kg via epidural catheter. General anaesthesia will be given as per standard technique. Repeat analgesia will be given as per duration of action of respective mode of analgesia given.The patients will then be transferred to the post anaesthesia care unit and monitored for pain at regular time intervals using an 11 point Numerical Rating Scale(NRS). If NRS> 4, then rescue analgesia will be given as per the group assigned. The patients will be followed up every 24 hours for 1 week to assess the quality of recovery using QoR 15 score.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Known gastrointestinal or genitourinary cancer patients ASA grade III-IV Patients undergoing oncological abdominal surgeries under general anaesthesia.

Exclusion Criteria

  • Patient refusal 2) BMI ≥ 30 kg/m 2 3) Clinically significant neurologic, psychiatric, CVS 4) Critically ill patient renal, respiratory and hepatic disease 5) Coagulation abnormalities 6) Local infection (for epidural) 7) Allergy to study drugs, pregnancy, drug abuse/ 8) Those who received analgesic, anxiolytic, antipschyciatric substance abuse medication within 6 hours before surgery 9) Redo surgery 10)Failure of extubation within 6 hours of surgery.

Outcomes

Primary Outcomes

Postoperative Quality of recovery using QoR 15 score

Time Frame: 1 week

Secondary Outcomes

  • Immediate Aldrete score(Return of bowel function in terms of peristalsis)

Investigators

Sponsor
Arpita Thombre
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Arpita Thombre

Pt JNM Medical College

Study Sites (1)

Loading locations...

Similar Trials